← board
BDPT
distress 5/10 · elevated risk$0.00-8%today-98% from 52w high
Revenue
pre-revenue
Liquidity
$0M
Runway
0.1 yrs
Shares 1y
+21%
Price & events
-94.9% over 6M
CatalystRating changeDilutionFinancingdashed = today
-7.7%
1D
-55.6%
1W
-76.7%
1M
-88.0%
3M
-93.6%
6M
-94.9%
1Y
-98.4%
2Y
-100.0%
5Y
-100.0%
All
Overview
- Market Cap
- $14.41K
- Volume
- 760.50K
- 52 Week Range
- $0.00 – $0.06
- Total Shares
- 12.01M
- Float Shares
- 11.76M
- % Held by Insiders
- 0.15%
- % Held by Institutions
- 0.00%
- RVOL
- 0.10x
- Beta
- 1.39
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 0
- No catalyst news yet.
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- no recent rating changes
Competitors
- none identified
Recent news
- none
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.